autologous transplantation
Showing 1 - 25 of >10,000
Diabetes After Total Pancreatectomy Trial in Shanghai (YD01-2022)
Recruiting
- Diabetes After Total Pancreatectomy
- YD01-2022
-
Shanghai, ChinaDepartment of Endocrinology and Metabolic Diseases, Ruijin Hospi
Aug 11, 2023
Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)
Not yet recruiting
- Malignant Lymphoma
- Multiple Myeloma
- Pentaisomaltose
- (no location specified)
Jan 5, 2023
Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Venetoclax
- +5 more
- (no location specified)
May 9, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)
Recruiting
- Macular Degeneration
- Autologous iPSC-derived RPE
-
Beijing, Beijing, ChinaBeijing Tongren Hospitol,Capital Medical University
Jun 30, 2022
Articular Cartilage Defect Trial in Guangzhou (Autologous costal osteochondral transplantation, Autologous iliac osteoperiosteal
Not yet recruiting
- Articular Cartilage Defect
- Autologous costal osteochondral transplantation
- Autologous iliac osteoperiosteal transplantation
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Southern Medical University
Jul 12, 2023
Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)
Completed
- Multiple Myeloma
-
Stanford, CaliforniaStanford University
Aug 17, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Autologous hematopoietic stem cell transplantation
- +2 more
-
La Jolla, CaliforniaScripps Green Hospital
Aug 16, 2022
T Cell Lymphoma Trial in Shanghai (Chidamide combined with BEAM)
Recruiting
- T Cell Lymphoma
- Chidamide combined with BEAM
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 27, 2022
Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)
Recruiting
- Head and Neck Cancer
- Submandibular Gland Stem Cell Transplantation
-
Groningen, NetherlandsUMCG
May 24, 2022
Autologous Epidermal Cell Transplantation Trial (Cultured autologous epidermal cell membrane)
Not yet recruiting
- Autologous Epidermal Cell Transplantation
- Cultured autologous epidermal cell membrane
- (no location specified)
May 31, 2023
Beta-Thalassemia Trial (CS-101 injection)
Not yet recruiting
- Beta-Thalassemia
- CS-101 injection
- (no location specified)
Sep 27, 2023
Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)
Active, not recruiting
- Mantle Cell Lymphoma
- R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
-
Basking Ridge, New Jersey
- +4 more
Dec 1, 2022
Premature Ovarian Failure Trial in Ulaanbaatar (stem cell therapy)
Not yet recruiting
- Premature Ovarian Failure
- stem cell therapy
-
Ulaanbaatar, MongoliaMongolian National University of Medical Science
Nov 13, 2023
Ischemic Stroke Trial in Guangzhou (Transplantation of self BMSCs)
Recruiting
- Ischemic Stroke
- Transplantation of self BMSCs
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
May 6, 2023
Aging Problems, Aging, Chronic Inflammation Trial in Ho Chi Minh City (autologous adipose-derived mesenchymal stem cell
Completed
- Aging Problems
- +2 more
- autologous adipose-derived mesenchymal stem cell transplantation
-
Ho Chi Minh City, District 05, VietnamDNA International Hospital
Apr 23, 2023
Infertility, Female, Mitochondrial, Elderly Trial in Peking (Autologous USC mitochondrial oocyte transplantation)
Enrolling by invitation
- Infertility, Female
- +3 more
- Autologous USC mitochondrial oocyte transplantation
-
Peking, Beijing, ChinaPeking University People's hospital
Aug 31, 2023
Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)
Recruiting
- Autologous Haematopoietic Stem Cell Transplant
- plerixafor + G-CSF
-
China, ChinaInvestigational Sites
May 4, 2022
Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)
Active, not recruiting
- Plasma Cell Myeloma
- Melphalan
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 21, 2022
Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)
Recruiting
- Multiple Myeloma
- Total Marrow irradiation,TMI
- Autologous hematopoietic stem cell transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)
Not yet recruiting
- Autologous Stem Cell Transplantation
- Conditioning
- modified BEAM
- BEAM
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023
B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)
Recruiting
- B-cell Lymphoma
- ASCT+CAR-T Cell Infusion
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)
Recruiting
- Well-being of Caregivers (Caregiver Strain Index)
- home care
-
Durham, North CarolinaDuke University Medical Center
Jan 25, 2023